The Effective Statistician - in association with PSI
When should we move beyond Excel for health technology assessment?
I sit down with Dr Robert Smith to explore why increasingly complex health economic models call for a different approa...
How can we make sure our analyses lead to action?
I’m joined by Dr. Annika Bergbauer, economist, IT management consultant, and host of Datenaffaire, to explore how we can put people at ...
How can statisticians improve dose decisions and drive innovation in their everyday work? I speak with Marie-Karelle Rivière and Anaïs Andrillon from Saryga about Project Optimus, their approach...
What helps us build a fulfilling career in statistics beyond technical expertise?
In this episode, I speak with Godwin Yung, who leads the Statistical Methodology group at Roche–Genentec...
How do we generate evidence that supports regulatory approval, patient access, and better care?
In this episode, I talk with Gorana Capkun from Merck Healthcare, where she leads the pati...
How can we make statistics meaningful to someone who does not work with it every day? I talk with Steve Mallett about his work with the PSI Schools team and the lessons it offers for training co...
Will artificial intelligence make statisticians obsolete—or make our expertise even more valuable?
In this episode, I speak with independent statistical consultant Chris Harbron about ho...
How can we build a patient-reported outcome strategy that captures the patient voice and strengthens clinical development?
In this episode of The Effective Statistician Podcast, I speak ...
In this episode, I talk with Ning Leng, Ph.D., Director II, Data and AI Acceleration Group, Data & Statistical Sciences at AbbVie, about the growing role of the R Consortium in the pharmaceu...
Cancer treatments have changed dramatically over the past decade, but have our dose-finding strategies kept pace?
In this episode, I speak with Dr. Ayon Mukherjee, who leads statistical ...